Buitenkant, Joanne Vava – Trademark Portfolio
Entity Type: 01
Buitenkant, Joanne Vava holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VAVA BUITENKANT CREATIVE DIRECTOR UNITING ART & COPY SEAMLESSLY BUITENKANT ADVERTISING & DESIGN. The owner is based in Brooklyn, NY.
260 Ocean Parkway, Apt 6C
Brooklyn, NY 11218
Showing of trademarks Trademarks
Trademark Classifications
Buitenkant, Joanne Vava's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Buitenkant, Joanne Vava have?
Buitenkant, Joanne Vava has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Buitenkant, Joanne Vava file in?
Buitenkant, Joanne Vava files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are Buitenkant, Joanne Vava's most well-known trademarks?
Buitenkant, Joanne Vava's registered trademark portfolio includes well-known marks such as VAVA BUITENKANT CREATIVE DIRECTOR UNITING ART & COPY SEAMLESSLY BUITENKANT ADVERTISING & DESIGN. These are among 1 currently registered trademark in the portfolio.
What is Buitenkant, Joanne Vava's trademark registration success rate?
Buitenkant, Joanne Vava has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.